Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipolytic Effects of GH and Acipimox in Hypopituitarism
NCT02782208Completed
- Sponsor
- Aarhus University
- Start
- Feb 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acipimox in insulin resistance (IR) (4 arms), sponsored by Aarhus University. Primary endpoint: Lipolytic activity measured as area under the curve (AUC) for FFA at 1 year. Started Feb 2016; status: completed.
02
Drugs
acipimox
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02782208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02782208.